tiprankstipranks
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
HALO
Halozyme
RESEARCH TOOLSreports

Halozyme (HALO) Income Statement

1,176 Followers

Halozyme Income Statement

Last quarter (Q4 2025), Halozyme's total revenue was $451.77M, an increase of 51.60% from the same quarter last year. In Q4, Halozyme's net income was $-141.59M. See Halozyme’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.40B$ 1.02B$ 829.25M$ 660.12M$ 443.31M
Gross Profit
$ 1.09B$ 855.91M$ 636.89M$ 520.81M$ 361.90M
Operating Expenses
$ 274.88M$ 304.43M$ 299.32M$ 253.28M$ 86.00M
Depreciation and Amortization
$ 88.05M$ 81.31M$ 84.86M$ 49.64M$ 3.00M
EBITDA
$ 904.34M$ 656.54M$ 451.95M$ 315.51M$ 259.04M
Operating Income
$ 816.29M$ 551.48M$ 337.57M$ 267.53M$ 275.90M
Other Income/Expenses
$ -349.42M$ 5.66M$ 10.76M$ -18.61M$ -27.38M
Pretax Income
$ 466.88M$ 557.13M$ 348.33M$ 248.92M$ 248.52M
Net Income
$ 316.89M$ 444.09M$ 281.59M$ 202.13M$ 402.71M
Per Share Metrics
Basic EPS
$ 2.64$ 3.50$ 2.13$ 1.48$ 2.86
Diluted EPS
$ 2.56$ 3.43$ 2.10$ 1.44$ 2.74
Weighted Average Shares Outstanding
 119.84M 126.83M 131.93M 136.84M 140.65M
Weighted Average Shares Outstanding (Diluted)
 123.90M 129.42M 134.20M 140.61M 146.80M
Currency in USD

Halozyme Earnings and Revenue History